OBJECTIVE: The purpose of this study was to determine whether there is a shift in the timing of @entity3036 in relation to delivery and whether traditional symptoms precede impending @entity3036 . STUDY DESIGN: A multicenter analysis of data from @entity1 with @entity3036 from March 1996 through February 2001 at the University of Cincinnati, the University of Tennessee, Memphis, and Central Baptist Hospital, Lexington. Data were collected regarding the relationship of the @entity1 's first @entity410 to delivery, prodromal symptoms, neuroimaging studies, use of @entity2399 , antihypertensive therapy, and follow-up medical care. The analysis focused on @entity1 who had late @entity3036 . RESULTS: During the study period, 89 @entity1 were diagnosed with @entity3036 . Twenty-nine @entity1 (33%) had @entity3036 , of whom 23 @entity1 (79%) had late onset (>48 hours). Interestingly, only 5 of these 23 @entity1 (22%) had been previously diagnosed with @entity1468 . Twenty-one @entity1 (91%) with late @entity3036 had at least 1 prodromal symptom, and 12 @entity1 (52%) had >1 symptom that heralded the @entity410 : 20 @entity1 (87%) had @entity10 ; 10 @entity1 (44%) had visual changes; 5 @entity1 (22%) had @entity390 or @entity391 ; and 2 @entity1 (9%) experienced @entity158 . Only 7 of these 21 @entity1 (33%) sought care for their symptoms, of whom 6 @entity1 (86%) had clinical evidence of @entity1468 that was not considered by the treating physician. Among all @entity1 with @entity3036 , there were 7 cases of @entity1174 , 3 cases of @entity3126 , 3 cases of @entity1143 , 2 cases of disseminated @entity5642 , and no cases of @entity204 . CONCLUSION: Current obstetric treatment in the United States has resulted in a shift of @entity3036 toward the postpartum period, with most cases being seen as late post partum. To reduce the rate of late @entity3036 , efforts should be directed to the education of the health care providers and @entity1 regarding the importance of prompt reporting and evaluation of symptoms of @entity1468 during the postpartum period.

Late XXXX : a preventable disease?

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient'] @entity1143 :: ('MESH:D010996', 'Disease') :: ['pleural effusion'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure'] @entity390 :: ('MESH:D009325', 'Disease') :: ['nausea'] @entity2399 :: ('MESH:D008278', 'Chemical') :: ['magnesium sulfate'] @entity3126 :: ('MESH:D011654', 'Disease') :: ['pulmonary edema'] @entity391 :: ('MESH:D014839', 'Disease') :: ['vomiting'] @entity1174 :: ('MESH:D011015', 'Disease') :: ['aspiration pneumonia'] @entity5642 :: ('MESH:D004211', 'Disease') :: ['intravascular coagulation'] @entity3036 :: ('MESH:D004461', 'Disease') :: ['eclampsia', 'postpartum eclampsia'] @entity1468 :: ('MESH:D011225', 'Disease') :: ['preeclampsia'] @entity158 :: ('MESH:D010146', 'Disease') :: ['epigastric pain'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache'] @entity204 :: ('MESH:D003643', 'Disease') :: ['maternal death']
@entity3036 :: (MESH:D004461,Disease) :: ['postpartum eclampsia']
